PD64-12 THE COMBINATION OF SUNITINIB AND KETOCONAZOLE TARGETED AT THE TUMOR MICROENVIRONMENT IMPROVES THE EFFICACY OF ANTICANCER THERAPY

Authors :: Louis S Krane
Amanda Raines
Jacob W. Greenberg
Asim B. Abdel-Mageed
Hokyoung Kim
Josh Pincus
Source :: Journal of Urology. 203
Publication Year :: 2020
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2020.

Subjects :: Tumor microenvironment
Sunitinib
business.industry
Urology
medicine
Cancer research
Ketoconazole
business
medicine.drug

Full Text Access

Tools